Abbonarsi

Reevaluating Normal-Flow Low-Gradient Severe Aortic Stenosis: Clinical Phenotypes and Outcomes in Severe Aortic Stenosis Among Transcatheter Aortic Valve Replacement Patients - 02/04/25

Doi : 10.1016/j.echo.2024.12.010 
Amro Badr, MD a, Mustafa Suppah, MD a, Kamal Awad, MD a, Juan Farina, MD a, Bobbi Jo Heon, RCDS a, Rachel Wraith, RCDS a, Bishoy Abraham, MD a, Sara Kaldas, MD a, Vuyisile Nkomo, MD, MPH b, Reza Arsanjani, MD a, Chieh-Ju Chao, MD a, David Holmes, MD b, Said Alsidawi, MD a,
a Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona 
b Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota 

Reprint requests: Said Alsidawi, MD, Department of Cardiovascular Medicine, Mayo Clinic Arizona, 5777 E Mayo Boulevard, Phoenix, AZ 85054.Department of Cardiovascular MedicineMayo Clinic Arizona5777 E Mayo BoulevardPhoenixAZ85054

Abstract

Background

Aortic stenosis (AS) is a complex condition with various hemodynamic subtypes, each with distinct clinical profiles and outcomes. The aim of this study was to assess the characteristics and outcomes of different AS phenotypes on the basis of flow and gradient patterns.

Methods

In this retrospective cohort study, 930 patients who underwent transcatheter aortic valve replacement for severe symptomatic AS at Mayo Clinic sites from 2012-2017 were included. Patients were classified into three groups: high gradient (HG), low-flow low-gradient (LFLG), and normal-flow low-gradient (NFLG). Baseline clinical, echocardiographic, and computed tomographic characteristics, including aortic valve area, aortic valve calcium score, left ventricular ejection fraction, and the prevalence of tricuspid regurgitation, and atrial fibrillation were analyzed. One- and 5-year all-cause mortality outcomes were compared using Kaplan-Meier analysis and Cox proportional-hazards models.

Results

The final cohort included 273 patients in the NFLG group (29.4%), 563 in the HG group (60.5%), and 94 in the LFLG group (10.1%). After reevaluation and careful review of the echocardiograms, 41 patients with NFLG AS were reclassified into the LFLG group. Patients with LFLG AS had the highest prevalence of atrial fibrillation or flutter (60%) and tricuspid regurgitation (17%). Aortic valve calcium score was significantly lower in the NFLG group compared with the HG and LFLG groups. One-year mortality was highest in the LFLG group (17.4%), followed by the HG (13.9%) and NFLG (10.9%) groups, but the difference was not statistically significant (P = .20). The 5-year mortality rate was higher in the LFLG group (55.6%) compared with the NFLG (47.2%) and HG (47.9%) groups but did not reach statistical significance (P = .20).

Conclusions

LFLG AS was associated with more comorbidities and higher mortality compared with HG and NFLG AS, though differences in mortality were not statistically significant. The NFLG group, after close review and reclassification, showed the least significant AS. Randomized trials are needed to clarify the prognosis and management of NFLG AS.

Il testo completo di questo articolo è disponibile in PDF.

Central Illustration

Results based on AS subtype.



Central Illustration : 

Results based on AS subtype.


Central IllustrationResults based on AS subtype.

Il testo completo di questo articolo è disponibile in PDF.

Highlights

Measurement errors in echocardiographic assessment of AS are common.
NFLG severe AS is overrepresented because of measurement errors.
Arrhythmias and valvular diseases were more common in LFLG AS.
NFLG severe AS had the lowest AVCS.
Mortality was similar across subtypes after TAVR, potentially higher in LFLG AS.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Aortic stenosis, Transcatheter aortic valve replacement, High-gradient, Low-flow low-gradient, Normal-flow low-gradient, Echocardiography, Mortality

Abbreviations : AF, AS, AV, AVA, AVCS, CT, HG, HR, IQR, LFLG, LVEF, LVOT, LVSVI, MPG, MRI, NFLG, TAVR, TR, VTI


Mappa


 Philippe Pibarot, DVM, PhD, served as guest editor for this report.
 This publication was supported and/or funded by Mayo Clinic Arizona Cardiovascular Clinical Research Center. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the Mayo Clinic Arizona Cardiovascular Clinical Research Center.


© 2025  American Society of Echocardiography. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 38 - N° 4

P. 310-319 - aprile 2025 Ritorno al numero
Articolo precedente Articolo precedente
  • Machine Learning Identifies Clinically Distinct Phenotypes in Patients With Aortic Regurgitation
  • Brototo Deb, Christopher G. Scott, Hector I. Michelena, Sorin V. Pislaru, Vuyisile T. Nkomo, Garvan C. Kane, Juan A. Crestanello, Patricia A. Pellikka, Vidhu Anand
| Articolo seguente Articolo seguente
  • Utility of an Echocardiographic Machine Learning Model to Predict Outcomes in Intensive Cardiac Care Unit Patients
  • Samy Aghezzaf, Augustin Coisne, Kenza Hamzi, Solenn Toupin, Claire Bouleti, Charles Fauvel, Jean-Baptiste Brette, David Montaigne, Reza Rossanaly Vasram, Antonin Trimaille, Gilles Lemesle, Guillaume Schurtz, Edouard Gerbaud, Clément Delmas, Marc Bedossa, Jean-Claude Dib, Vincent Roule, Etienne Puymirat, Martine Gilard, Marouane Boukhris, Nicolas Mansencal, Nabil Bouali, Stephane Andrieu, Trecy Gonçalves, Jean-Guillaume Dillinger, Patrick Henry, Theo Pezel

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.